Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Avraham Gabay currently holds 745,145 shares of ORAMED PHARMACEUTICALS INC. (ORMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Avraham Gabay has been a net neutral trader of ORMP stock. They have purchased $0 and sold $0 worth of shares.
Avraham Gabay's most recent insider trade was on Mar 17, 2026, when they sold 95,889 shares at $0.00 per share.
Avraham Gabay serves as Executive at ORAMED PHARMACEUTICALS INC. (ORMP). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Avraham Gabay holds the position of Executive at ORAMED PHARMACEUTICALS INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Avraham Gabay has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Avraham Gabay was on Mar 17, 2026, when they purchased $0 worth of ORMP shares. This transaction involved 95,889 shares at N/A per share.
Avraham Gabay currently owns 745,145 shares of ORAMED PHARMACEUTICALS INC. (ORMP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Avraham Gabay's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Avraham Gabay has 2 Form 4 filings on record as an insider at ORAMED PHARMACEUTICALS INC..
Set alerts for Avraham Gabay and 40,000+ other insiders.